Viewing Study NCT00160602

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:53 AM

Ignite Modification Date: 2025-12-26 @ 2:43 AM

Study NCT ID: NCT00160602

Status: COMPLETED

Last Update Posted: 2020-12-01

First Post: 2005-09-08

Is NOT Gene Therapy: False

Has Adverse Events: False

Brief Title: A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

Sponsor: UCB Pharma

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module